CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464097528
- Phone
- 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure · Other events
- 4 Planned sale CEO sold 12,191 shares at $5.50 ($66,997)
- 4 Planned sale EVP, CHIEF MEDICAL OFFICER sold 511 shares at $5.50 ($2,808)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
- 4 Planned sale EVP, CHIEF FINANCIAL OFFICER sold 22,337 shares at $5.61 ($125,404)
- 144 Insider Sale of Securities
Page 8 of 37 · 731 filings